Author Archives: Ryan Miller

McNeill RS, Irvin DM, Miller CR.  BRAF mutations open doors to ENU-induced gliomagenesis.  American Journal of Pathology.  Epub Aug 17, 2016.  DOI: 10.1016/j.ajpath.2016.07.005.  PMID: 27543966

UNC-Chapel Hill researchers C. Ryan Miller, MD, PhD and Shawn Hingtgen, PhD show that glioblastomas are fundamentally different before and after surgery Read more on UNC News, UNC School of Pharmacy, and UNC Lineberger Comprehensive Cancer Center Pathways

UNC-Chapel Hill researcher C. Ryan Miller, MD, PhD, publishes two senior author publications in leading pathology and oncology journals Read more on UNC Lineberger Comprehensive Cancer Center Lineup

Results from a UNC Lineberger study, led by Carey Anders, MD and C. Ryan Miller, MD, PhD were published Monday in the journal Molecular Cancer Therapeutics. The preclinical study was the first to investigate one particular drug strategy as a treatment for breast cancer after it’s spread to the brain. Read...

C. Ryan Miller Six researchers, including C. Ryan Miller, MD, PhD, have been awarded 2014 University Cancer Research Fund (UCRF) Innovation Awards for promoting innovative and new ideas in cancer research at the University of North Carolina at Chapel Hill. Read more on UNC Lineberger Comprehensive Cancer Center Pathways

David Irvin, MR Read more here.

Robert S. McNeill, BS Read more here.

C. Ryan Miller, MD, PhD Why do some cancers spread rapidly to other organs and others don’t metastasize? A team of UNC researchers led by Norman Sharpless, MD, and including C. Ryan Miller, MD, PhD, have identified a key genetic switch that determines whether melanoma, a lethal skin cancer, spreads...

Robert S. McNeill, BS Read more here.

C. Ryan Miller, MD, PhD New findings by researchers at UNC Lineberger Comprehensive Cancer Center suggest that the most common form of malignant brain cancer in adults, glioblastoma (GBM), is probably not a single disease but a set of diseases, each with a distinct underlying molecular disease process. Read more...